당신은 주제를 찾고 있습니까 “luminex aries m1 – ARIES® System Workflow Overview“? 다음 카테고리의 웹사이트 https://chewathai27.com/you 에서 귀하의 모든 질문에 답변해 드립니다: https://chewathai27.com/you/blog. 바로 아래에서 답을 찾을 수 있습니다. 작성자 Luminex Corporation 이(가) 작성한 기사에는 조회수 9,614회 및 좋아요 20개 개의 좋아요가 있습니다.
Table of Contents
luminex aries m1 주제에 대한 동영상 보기
여기에서 이 주제에 대한 비디오를 시청하십시오. 주의 깊게 살펴보고 읽고 있는 내용에 대한 피드백을 제공하세요!
d여기에서 ARIES® System Workflow Overview – luminex aries m1 주제에 대한 세부정보를 참조하세요
An in depth look at how ARIES® can help increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today’s lean laboratory.\r
\r
The ARIES® Systems are Luminex’s sample to answer, real time PCR systems that are crafted to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today’s lean laboratory. ARIES® allows your lab to control each aspect of the sample to answer testing process, from sample accessioning through result reporting.\r
\r
http://www.luminexcorp.com/aries
luminex aries m1 주제에 대한 자세한 내용은 여기를 참조하세요.
ARIES® M1 System – Luminex Corporation – PDF Catalogs
A New Addition to the ARIES® Sample to Answer System The ARIES® M1 System* shares the same cassette-based sample to answer molecular diagnostic workflow as …
Source: pdf.medicalexpo.com
Date Published: 12/15/2021
View: 2494
Hệ thống Realtime PCR tự động ARIES M1
Công nghệ phân tích đa tác nhân của Luminex (xMAP) cho phép phân tích đồng thời lên tới 500 tác nhân sinh học trong một thể tích mẫu nhỏ, thường là một giọt …
Source: www.unitedscientific.com.vn
Date Published: 3/22/2021
View: 8443
ARIES® M1 | Luminex Corporation – CBRNE Tech Index
The ARIES® M1 is a real time PCR instrument that allows the user to control each aspect of the sample to answer testing process, from sample accessioning t.
Source: www.cbrnetechindex.com
Date Published: 10/6/2021
View: 5655
ARIES® M1—Welcome to the New Way to Work (IVD)
2006-2022 Luminex Corporation. A DiaSorin Company. All rights reserved.
Source: www.luminexcorp.com
Date Published: 11/2/2021
View: 5378
ARIES® and ARIES® M1 Systems – TECHNOPATH
Sample to answer, real time PCR systems designed for improved laboratory efficiency and workflow for infectious disease testing. The Luminex Aries® System …
Source: www.techno-path.com
Date Published: 9/22/2021
View: 8722
Luminex Aries M1 – yeedesign.me
Luminex Aries M1 CHALLENGE Most molecular diagnostic laboratories use a range of aging equipment and are looking to next generation…
Source: yeedesign.me
Date Published: 1/17/2022
View: 6144
Luminex Corporation Receives FDA Clearance and CE-IVD …
The ARIES M1 System is designed to empower satellite clinical laboratories to take advantage of the same benefits as Luminex’s higher …
Source: www.prnewswire.com
Date Published: 12/12/2021
View: 9081
Class 2 Device Recall ARIES System, ARIES M1 System
Product, Luminex Aries M1 System Model: Aries M6V1 Aries Software v1.0. For In Vitro Diagnostic Use in clinical laboratories. Scanner Label/Labeling:
Source: www.accessdata.fda.gov
Date Published: 6/24/2022
View: 6608
주제와 관련된 이미지 luminex aries m1
주제와 관련된 더 많은 사진을 참조하십시오 ARIES® System Workflow Overview. 댓글에서 더 많은 관련 이미지를 보거나 필요한 경우 더 많은 관련 기사를 볼 수 있습니다.
주제에 대한 기사 평가 luminex aries m1
- Author: Luminex Corporation
- Views: 조회수 9,614회
- Likes: 좋아요 20개
- Date Published: 2015. 11. 5.
- Video Url link: https://www.youtube.com/watch?v=L33ZxnMQI8A
CBRNE Tech Index Products
Product Synopsis
The ARIES® M1 is a real time PCR instrument that allows the user to control each aspect of the sample to answer testing process, from sample accessioning through result reporting.
Luminex Aries M1 — yeedesign.me
CHALLENGE
Most molecular diagnostic laboratories use a range of aging equipment and are looking to next generation systems to consolidate their testing into fewer platforms. There is a premium placed on space and efficiency, and each device must earn its place in the laboratory. Luminex’s goal was to develop an instrument that simplified the laboratory’s workflow and provided a premium user experience. Our challenge was to address these requirements by fusing multiple technologies into a next generation standalone device. I was tasked by M3 to implement a bold new form to highlight the system’s advantages and represent the Luminex brand.
SOLUTION
As a team we created an internal architecture that was a significant departure from Luminex’s original product vision but delivered several important benefits. Orienting the internal components vertically reduced the device to its minimum possible footprint, while providing a natural landing for its large touch-screen interface. The sample-magazine touch points are cleverly designed to slide effortlessly into either the upper or lower chamber, managing the ergonomic challenges of having different bay heights. Introducing a dramatic form and color scheme that highlight the ARIES® System’s functional and visual advantages, make the system more recognizable in the lab environment.
Luminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System
The ARIES M1 System is designed to empower satellite clinical laboratories to take advantage of the same benefits as Luminex’s higher throughput ARIES System, with features such as an intuitive system interface, STAT or batch testing, and true walkaway capability. The system extracts, amplifies and detects nucleic acid targets from a variety of sample types. Once the cassettes are loaded onto the instrument, results are generated without additional technical intervention. The system can process up to six different samples, and one to six assays, at a time.
“In developing the ARIES family of systems, we listened closely to the needs of our customers and crafted these products to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today’s lean laboratory. We are now adding another system based on customer feedback, and in doing so, expanding our market reach,” said Homi Shamir, President and Chief Executive Officer of Luminex. “Luminex now has the broadest offering of low-plex and high-plex sample to answer systems for clinical laboratories performing molecular diagnostic testing. And, with the acquisition of NSPH behind us, we can focus on continuing to move products in our pipeline towards commercialization and realizing the value in our newly acquired asset.”
The new system will be on display at the upcoming AACC Annual Scientific Meeting & Clinical Lab Expo which is happening July 31–August 4 in Philadelphia, PA.
Learn more or request a demo, visit: www.luminexcorp.com/ARIES
About the ARIES® Systems
The ARIES® Systems are sample to answer molecular diagnostic platforms designed to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today’s lean laboratory environment. ARIES® uses internal barcode scanning and other advanced features to minimize operator errors. An integrated touchscreen PC eliminates the need for a separate computer, standalone keyboard, and mouse, maximizing valuable bench space. The low throughput ARIES® M1 System provides one module with the ability to run one to six different assays according to the ARIES® Universal Assay Protocol. The higher throughput ARIES® System provides two independent modules, each which support from one to six cassettes, allowing for both STAT and Batch testing of IVD and homebrew assays using MultiCode® Reagents when using a universal assay protocol.
About Luminex Corporation
Luminex is committed to applying its passion for innovation toward creating breakthrough solutions to improve health and advance science. The company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture multi-analyte platform, MultiCode® real-time polymerase chain reaction (PCR), and multiplex PCR-based technologies, that deliver cost-effective rapid results to clinicians and researchers. Luminex’s technology is commercially available worldwide and in use in leading clinical laboratories, as well as major pharmaceutical, diagnostic, biotechnology and life science companies. Luminex is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, biodefense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.
Statements made in this release that express Luminex’s or management’s intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. Forward-looking statements in this release include statements regarding the available market for ARIES®, future revenue growth anticipated for ARIES®, and the development, testing and regulatory approval progress of our pipeline products, including ARIES® related assays. The words “believe”, “expect”, “intend”, “anticipates”, “confident”, “will”, “could”, “should”, and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. It is important to note that the Company’s actual results or performance could differ materially from those anticipated in such forward-looking statements. Factors that could cause Luminex’s actual results or performance to differ materially include risks and uncertainties relating to, among others, our ability to launch products on time, the timing of regulatory approvals, the outcome of clinical trials as well as the risks discussed under the heading “Risk Factors” in Luminex’s Reports on Forms 10-K and 10-Q, as filed with the Securities and Exchange Commission. The forward looking statements contained herein represent the judgment of Luminex as of the date of this press release, and Luminex expressly disclaims any intent, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in Luminex’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
Contacts:
Luminex Investor Contact
Harriss Currie, 512.219.8020
Sr. Vice President of Finance and CFO
[email protected]Luminex Media Contact
Christine Valle, 512.219.8020
Sr. Manager, Global Marketing
[email protected]Photo – http://photos.prnewswire.com/prnh/20160705/386171
Logo – http://photos.prnewswire.com/prnh/20150201/172702LOGO
SOURCE Luminex Corporation
Related Links
http://www.luminexcorp.com
Class 2 Device Recall ARIES System, ARIES M1 System
Class 2 Device Recall ARIES System, ARIES M1 System Date Initiated by Firm June 29, 2018 Date Posted August 19, 2019 Recall Status1 Terminated 3 on April 28, 2021 Recall Number Z-2292-2019 Recall Event ID 81420 510(K)Number K151917 K160517 K162772 K161495 Product Classification real time Nucleic acid amplification system – Product Code OOI
Product Luminex Aries M1 System
Model: Aries M6V1
Aries Software v1.0
For In Vitro Diagnostic Use in clinical laboratories.
Scanner Label/Labeling:
JADAK
JDK-2330 REV B 170512-017 Code Information ARIES System UDI: 00840487101537 ARIES M1 System UDI: 00840487100080 ARIES-M12V1-IVD, ARIES System ARIES-M6V1-IVD, ARIES M1 System CN-0321-01, ARIES System Handheld Barcode Scanner All scanners manufactured after April 2017 and including Part Number JDK-2330 Rev B. Recalling Firm/
Manufacturer Luminex Corporation
12212 Technology Blvd
Austin TX 78727-6101
For Additional Information Contact Wendy Ricker
608-203-8936 Manufacturer Reason
for Recall An incorrect control board and firmware installed in some of the Hand Held Barcode Scanners could result in sample/patient mismatch or duplicate results (from other patients specimens) for a patient order. FDA Determined
Cause 2 Process control Action On July 10, 2018, the firm sent an “URGENT: FIELD SAFETY NOTICE” to customers via email (with a follow-up telephone call) informing them that they may have received an affected barcode scanner. The Notice explained that when the potentially affected barcode scanner is used on multiple ARIES¿ cassettes at the same time, the system may prepopulate the Sample ID field with a previously stored sample ID. This field will be overwritten by scanning or manually entering a sample, but in the event the ARIES cassette is not scanned, the prepopulated field may cause the incorrect association of sample identification to occur. The firm has conducted internal investigation that have shown that the firmware version on hand-held barcode scanner contained the incorrect version of firmware approved for use with the ARIES¿ Systems. Given that the ARIES¿ System barcode scanner (CN-0321-01 /JDK-2330 Rev B) has the potential to contribute to an incorrect result by creating the possibility that a Patient/Sample ID may be assigned to the wrong cassette, we are voluntarily initiating a recall to ensure no additional handheld scanners have this discrepant firmware. There have not been any adverse events associated with the use of the ARIES¿ System barcode scanners at this time. To confirm whether or not the customer’s particular barcode scanner is affected, the firm is advising its customer to verify the firmware version of the handheld barcode scanner by following the attached instructions (“Confirming the Firmware Version on the ARIES Hand-Held Barcode Scanner”) . An affected unit will include the labeling JDK-2330 Rev B on the underside of the scanner AND will have firmware version PAACES00-002-R03 or CAACES00-002-R03. Please contact Technical Support if you identify a discrepant barcode scanner model. Correct Model and Firmware (below) Model/Rev. Firmware Version JDK-2330 Rev B. PAACES00-001-R03 CAACES00-001-R03 If the in Quantity in Commerce 153 (140 U.S. and 13 O.U.S.) Distribution Worldwide distribution. US nationwide, Canada, Ireland, Netherlands, Singapore, Thailand, and United Kingdom Total Product Life Cycle TPLC Device Report 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55. 510(K) Database 510(K)s with Product Code = OOI and Original Applicant = LUMINEX CORPORATION
키워드에 대한 정보 luminex aries m1
다음은 Bing에서 luminex aries m1 주제에 대한 검색 결과입니다. 필요한 경우 더 읽을 수 있습니다.
이 기사는 인터넷의 다양한 출처에서 편집되었습니다. 이 기사가 유용했기를 바랍니다. 이 기사가 유용하다고 생각되면 공유하십시오. 매우 감사합니다!
사람들이 주제에 대해 자주 검색하는 키워드 ARIES® System Workflow Overview
- Luminex Corporation (Business Operation)
- ARIES
- Molecular Diagnostics
- Cepheid
- Genexpert
- Becton Dickinson (Business Operation)
- Diagnostics
- BDMax
- Analyte Specific reagents
- BioFire
- LDT
- Laboratory Developed Test
- Microbiology
- Molecular
- clinical diagnostics
- Assay Workflow
- Sample to Answer
ARIES® #System #Workflow #Overview
YouTube에서 luminex aries m1 주제의 다른 동영상 보기
주제에 대한 기사를 시청해 주셔서 감사합니다 ARIES® System Workflow Overview | luminex aries m1, 이 기사가 유용하다고 생각되면 공유하십시오, 매우 감사합니다.
